An interventional study of Virtually Monitored Home-Based Prehabilitation Program in Prehabilitation, Preoperative Care and Elective Surgical Procedures, sponsored by Queen's University. Not yet recruiting at 3 sites in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-15.
Sponsored by Queen's University · Not applicable, Interventional, and Supportive care
The goal of this clinical trial is to learn if a virtually monitored, home-based prehabilitation program is feasible and acceptable for adults undergoing major elective surgery. The main questions it aims to answer are:
Researchers will compare the prehabilitation program to standard preoperative care to see if the intervention is feasible to implement and whether it may help reduce postoperative complications.
Participants will:
The PRIME pilot trial aims to investigate whether a virtually monitored, home-based multimodal prehabilitation is feasible and can improve postoperative outcomes in adult patient populations undergoing major elective intra-thoracic, intra-abdominal, or orthopedic surgery.
The goal of a prehabilitation program is to optimize a patient's health status before surgery to reduce postoperative morbidity and enhance recovery. Despite advances in perioperative care, postoperative morbidity remains high, particularly in frail, obese, or older populations. Multimodal prehabilitation which includes physical exercise, nutritional optimization, and psychological support has demonstrated potential benefits in small trials and feasibility studies, yet definitive evidence remains limited. Intensive in-person prehabilitation, though effective, is not feasible for most centers due to resource limitations. Conversely, home-based programs, while pragmatic, have shown inconsistent adherence and outcomes. This study proposes a virtually monitored, home-based multimodal prehabilitation program designed to balance feasibility, adherence, and effectiveness, using the CloudDX® remote monitoring platform. The program includes exercise prescriptions, nutritional support, mindfulness exercises, and participant accountability through app-based monitoring.
The study will be conducted as a multicenter pilot randomized controlled trial at Kingston Health Sciences Centre, The Ottawa Hospital, and Hamilton Health Sciences. A total of 120 adult patients scheduled for major elective intra-thoracic, intra-abdominal, or orthopedic surgery will be randomized 1:1 to receive either standard preoperative care or the multimodal prehabilitation intervention. Participants in the intervention group will complete baseline questionnaires and receive prehabilitation consultation and education after onboarding to the CloudDX virtual platform using a cellular-enabled tablet provided to them, or their own device. The structured prehabilitation activities will be completed over a minimum of three weeks before surgery.
Primary objectives focus on feasibility, specifically recruitment rates and adherence to the intervention. Adherence will be tracked via the CloudDX® platform. Secondary objectives include assessing the program's impact on postoperative complications (using the Comprehensive Complication Index), mortality, disability (WHODAS 2.0), length of hospital stay, readmission rates, functional capacity (6-Minute Walk Test, CHAMPS, grip strength), quality of life (EQ-5D-5L), and nutritional status (PG-SGA).
Data will be collected through patient interaction, app-based monitoring, and medical record review. All study personnel will receive standardized training, and a detailed Manual of Operations will guide procedures at all sites. Data will be entered into a secure, REDCap electronic database using study-specific IDs, with source documents retained for verification. To ensure data quality, the Project Office will review monthly reports on enrollment, follow-up, and data completeness. The database will have built-in validity and range checks, with multi-level data validation and regular quality control reports shared with sites. All study records will be stored securely for at least five years post-study, with controlled access. Additionally, case histories with records of all observations and data related to the investigation will be maintained for each participant. Data will be reported on a hard copy case report form as well as being entered onto online database.
Descriptive statistics (means, medians, standard deviations, interquartile ranges, proportions) will be used to characterize the study sample. The outcomes of the pilot study will be descriptive in nature and will focus on feasibility measures, including recruitment, adherence, case report form completion, patient satisfaction, and withdrawal rates. Binary outcomes will be summarized using proportions with corresponding 95% confidence intervals. Differences in continuous outcomes will be described using the difference in means with corresponding 95% confidence intervals. All analyses will follow intent-to-treat (ITT) principles, with the ITT population defined as all randomized participants. Baseline characteristics will be summarized descriptively.
The study will be conducted in compliance with the protocol, principles laid down in the Declaration of Helsinki, Good Clinical Practice (GCP), as defined by the International Conference on Harmonisation (ICH), and all applicable laws and regulations of Canada.
By addressing the critical gap in accessible prehabilitation services, this trial aims to establish a scalable model that can be integrated across Canadian healthcare settings. The results of this pilot will inform the design and conduct of a larger definitive randomized trial.
1,332 studies on the registry are indexed under Postoperative Complications; 311 are open to participants now.
This study's planned enrollment of 120 is close to the median of 114 across 766 interventional studies indexed under Postoperative Complications.
Browse Postoperative Complications studies →Queen's University is the lead sponsor of 207 studies on the registry; 16 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in this arm will receive a home-based, virtually monitored multimodal prehabilitation program. The intervention includes aerobic and strength exercise prescriptions, nutritional counseling, mindfulness breathing exercises, and 36 Premier Protein® shakes. Participants will use the CloudDX® virtual care platform via a provided tablet or their own device to support adherence and track progress.
Behavioral: Virtually Monitored Home-Based Prehabilitation Program
Participants in this arm will receive standard preoperative care as per current clinical practice. They will not receive any structured prehabilitation components during the study period.
A multimodal, home-based prehabilitation program delivered via the CloudDX® virtual platform. Participants in the intervention group will be given a comprehensive prehabilitation pamphlet including: 1. a prescription for aerobic and strength exercises to be completed each week 2. nutritional counselling 3. descriptions of mindfulness deep breathing exercises 4. 36 Premier Protein shakes The participants will complete baseline questionnaires and receive prehabilitation consultation and education after onboarding to the CloudDX virtual platform using a cellular-enabled tablet provided to them, or their own device.
Feasibility of recruiting patients in a timely manner across local and outside sites
We will aim for a patient recruitment rate of 20 patients per month. A recruitment rate of greater than 10 but less than 20 patients per month will be considered feasible with modifications for the definitive study. Feasibility outcomes will be assessed according to the traffic light system. If the results fall within the 'green light' range, the definitive study will proceed as planned. Any results falling into the 'yellow light' range will require review and changes to the protocol before proceeding to the definitive phase. If results fall within the 'red light' range, the study will be considered not feasible without major modifications.
Time frame: From the start to end of patient recruitment (2 years)
Adherence with virtually monitored home-based prehabilitation program
Adherence will be monitored through the CloudDX activity tracker completed by the study participants. The number of interventions completed will be divided by the number of interventions prescribed to calculate the percent adherence to the overall prehabilitation program. If the mean reported adherence is greater than 80% with an associated lower bound of a 95% CIs of greater than 65%, this will support the feasibility of a definitive study. A mean adherence of greater than 60% (and associated lower bound of a 95% CIs of greater than 50%) but less than 80% will be considered feasible with modifications for the definitive study.
Time frame: From enrolment to the day of scheduled surgery (3 week timespan)
Postoperative complications
30-day CCI will be used. This is a scoring system used to quantify the overall burden of postoperative complications. It consolidates multiple complications into a single score ranging from 0 (no complications) to 100 (death). Each complication is weighted based on severity and impact, providing a cumulative measure that reflects the total morbidity a patient experiences. A severe postoperative complication will be defined as a CCI score of 20 or more. All complications occurring within 30 days of the index operation will be included in the CCI calculation.
Time frame: 30 days post-surgery
Mortality
30-day Postoperative Mortality: Death from any cause occurring within 30-days of the index operation.
Time frame: 30 days post-surgery
Disability
30-day patient-reported disability: This will be assessed using the WHO Disability Assessment Schedule V.2.0 (WHODAS).
Time frame: 30 days post-surgery
Length of stay and readmission
Postoperative Length of Stay (LOS): Postoperative LOS will be calculated as the number of days following the index surgery (i.e., postoperative day 0) that the patient remains in hospital. Every morning that the patient remains in hospital will count as an added day to postoperative LOS. 30-day Readmission: Following discharge from their index postoperative stay, if a patient is readmitted to any hospital for any reason within 30-days of their index operation, this will be counted as an outcome event. Reason for readmission will be recorded.
Time frame: Length of stay: From day of surgery to date of documented discharge, assessed up to 30-days after surgery. Readmission: From day of surgery until date of first documented hospital readmission, assessed up to 30-days post-surgery
European Quality of Life 5 Dimensions 5 Level Version (EQ5D5L)
Assessed using the European Quality of Life 5 Dimensions 5 Level Version (EQ5D5L). This questionnaire measures five dimensions-mobility, self-care, usual activities, pain/discomfort, and anxiety/depression-each with 5 severity levels (1=No problem, 5=Extreme problem). It is then scored by creating 5-digit health profiles (e.g., 11111 = No problem for all dimensions).
Time frame: Assessed at each major assessment point throughout the study. (1) Baseline - Day 0 (2) 2 days prior to surgery (3) 30 days after surgery
Nutritional Status
Assessed with the Patient-Generated Subjective Global Assessment (PG-SGA).
Time frame: Assessed at each major assessment point throughout the study. (1) Baseline - Day 0 (2) 2 days prior to surgery (3) 30 days after surgery
Percentage of patients approached that are subsequently enrolled
The proportion of eligible patients approached for study participation who provide informed consent and are successfully enrolled in the study.
Time frame: From initial patient approach until enrolment is completed
Case Report Form Completion
The percentage of case report forms for enrolled patients that are completed in their entirety without missing data, based on pre-specified required data elements.
Time frame: From enrolment until final data entry for each participant.
Patient Satisfaction With Prehabilitation Program
The percentage of participants randomized to the prehabilitation group who report that they would enrol in the program again.
Time frame: After the 3 week prehabilitation program; before surgery
Proportion of Participants Who Withdraw Consent to Participate
The proportion of participants who withdraw consent for any reason after enrolment and prior to study completion.
Time frame: From enrolment until final study follow-up (30 days postoperative).
6-Minute Walk Test Distance
Maximal distance achieved during the 6-minute walk test in metres.
Time frame: (1) Baseline (2) 2-days prior to surgery (3) 30-days after surgery
Self-reported physical activity
Assessed using the Community Healthy Activities Model Program for Seniors (CHAMPS) survey.
Time frame: (1) baseline (2) 2-days prior to surgery (3) 30-days after surgery
Hand Grip Strength
Peak hand grip strength in kilograms measured by a hand dynamometer.
Time frame: (1) Baseline (2) 2-days before surgery (3) 30-days after surgery
Leg strength
Dominant leg strength will be assessed using a HUMAC NORM Dynamometer. The peak torque recorded after three attempts will be presented as leg strength (in newton-meters).
Time frame: (1) Baseline (2) 2-days before surgery (3) 30-days after surgery
Plan to share: Undecided
This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.